|
Hits:96 , posted at 2026/2/10 10:53
In modern medical diagnostic research,
molecular imaging (specifically Positron Emission Tomography, or PET) has
become increasingly vital. It offers not only high specificity but also
provides researchers with biological information at the molecular level.
Once labeled, peptide molecules act as
molecular probes in imaging technologies to meet the needs of various
pharmacological studies, such as:
-
Early diagnosis of diseases.
-
Real-time visualization of the potential biochemical processes
involved in disease progression.
-
Tracking the entire course of disease
treatment.
Bifunctional reagents link peptides and
chelate metal elements, serving as targeted probes in molecular imaging for
research into targeted tumor therapy. Furthermore, by labeling various metal
elements, these reagents can be used to prepare proteomics multiplex
quantitative reagents. These are essential for the screening, identification,
and classification of tumor biomarkers.
Because of
these capabilities, both bifunctional reagents and peptides containing them
have significant application prospects in oncology research.
As a professional biotechnology company,
CSBio provides a wide range of products to support this field, including:
-
Various bifunctional reagents and bifunctional reagent-class
peptides.
-
High-quality peptide raw materials and reagents validated per
US FDA GMP guidelines.
-
Specialized PET peptide reagents.
|
PET Peptide
|
|
Catalog Number
|
Product Name
|
Sequence
|
|
CS34563
|
NOTA-RGD
|
NOTA-Arg-Gly-Asp
|
|
CS34564
|
NOTA-TATE-RGD
|
NOTA-Glu{PEG4-Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]-PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr
|
|
CS9412
|
NOTA-CPCR4-2
|
Cyclo { (D-Tyr)-(D-NMe-Orn)-(AMBS-NOTA)-Arg-(2-Nal)-Gly}
|
|
CS9539
|
NOTA-3PTATE-RGD
|
NOTA-(Bn-p-SCN)-PEG4-Glu{PEG4-Cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]-PEG4-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr
|
|
CS34565
|
NOTA-TATE-PRGD2
|
NOTA-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr-(Arg-Gly-Asp)2
|
|
CS9418
|
NOTA-3PRGD2
|
NOTA-PEG4-Glu{PEG4-cyclo[Arg-Gly-Asp-(D-Tyr)-Lys]}₂
|
|
CS15388
|
PSMA-11
|
Glu-NH-CO-NH-Lys(Ahx)-HBED-CC
|
|
CS17098
|
PSMA-617
|
DOTA-Amc-Nal-Lys-CO-Glu-OH
|
|
CS2575
|
DOTA-TATE
|
DOTA-(D-Phe)-Cys-Tyr-(D-Trp)-Lys-Thr-Cys-Thr [Disulfide Bond: Cys³-Cys⁸]
|
|
CS15398
|
NODAGA-LM3
|
NODAGA-p-Cl-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS15736
|
DOTA-LM3
|
DOTA-p-Cl-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS11123
|
DOTA-JR11
|
DOTA-Cpa-c[D-Cys-Aph(Hor)-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS34566
|
NODAGA-JR11
|
NODAGA
-Cpa-c[D-Cys-Aph(Hor)-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS34567
|
DOTA-JR10
|
DOTA-p-NO2-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS34568
|
NODAGA-JR10
|
NODAGA-p-NO2-Phe-c[D-Cys-Tyr-D-Aph(Cbm)-Lys-Thr-Cys]-D-Tyr-NH2
|
|
CS34569
|
NOTA-MAL-Cys40-Exendin-4
|
NOTA-MAL-Cys40-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
|
|
CS34570
|
NOTA-Exendin-4
|
NOTA-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
|
|
CS9409
|
DOTA-Nal³-Octreotide
|
DOTA-(D-Phe)-Cys-(1-Nal)-(D-Trp)-Lys-Thr-Cys-Thr-ol [Disulfide Bond: Cys³-Cys⁸]
|
|
CS12890
|
[DOTA-WT-pHLIP(D)]
|
DOTA-(Bn-pSCN)-Ala-Cys-Glu-Gln-Asn-Pro-Ile-Tyr-Trp-Ala-Arg-Tyr-Ala-Asp-Trp-Leu-Phe-Thr-Thr-Pro-Leu-Leu-Leu-Leu-Asp-Leu-Ala-Leu-Leu-Val-Asp-Ala-Asp-Glu-Gly-Thr [All D amino acids]
|
|
CS9441
|
IMP466
|
NOTA-(D-Phe)-Cys-Phe-(D-Trp)-Lys-Thr-Cys-Thr-OL [Disulfide Bond: Cys³-Cys⁸]
|
|
CS9243
|
DOTA-Ahx-Lys40 –Exendin
|
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser
–(Lys40-Ahx-DOTA)
|
|
CS34571
|
T140
|
Arg-Arg-Nal-Cys-Tyr-Arg-Lys-(D-Lys)-Pro-Tyr-Arg-Cit-Cys-Arg [Disulfide Bond: Cys⁴-Cys¹³]
|
|
CS34572
|
FC131
|
(D-Tyr)-Arg-Arg-(2-Nal)-Gly [Lactam Bond: (D-Tyr)¹-Gly⁵]
|
|